Funded Projects › H2020
IMI-PainCare · Improving the care of patients suffering from acute or chronic pain
There is a very high need for improving the management of pain. Acute and persistent pain of different origins represent a common medical, social, and economic burden, and its pharmacotherapy is often inadequate. To advance management of pain patients and support decision making in clinical practice, more predictive assessments of treatment success are needed. The development of analgesics is onerous because promising preclinical data often do not translate into the clinic. Improved pharmacodynamic biomarkers could define whether nociceptive signalling is adequately modulated by a new drug, so increasing the chance of successful translation and greatly reducing the risk in initiating clinical development. Further, the pathophysiology of chronic pelvic pain indications is poorly understood and no adequate preclinical models are available, precluding focused preclinical research and leaving affected patients with little hope of relief. IMI-PainCare aims at making advances in these three pain areas in a complementary manner. Three subprojects will address specific scientific challenges. Subproject PROMPT will identify Patient Reported Outcome Measures as tools to standardise assessments of treatment success of acute and chronic pain in Real World conditions and controlled trials, and so improve its management; subproject BioPain will validate the translatability of pharmacodynamic biomarkers and PK-PD modelling in pain pathways of healthy subjects and preclinical species, thereby offering tools to improve drug development; subprojectTRiPP will identify biomarkers and novel therapeutic pathways of clinical phenotypes of patients with chronic pelvic pain, which after back-translation, can improve how preclinical models reflecting human diseases.The goal of IMI-PainCare is to improve the care of patients with acute or chronic pain by providing a toolbox to streamline the development process for novel analgesic drugs and to improve treatment quality in clinical practice.
Consortium · 41 organisations
RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
DE · €1,019,588
ENDODIAG
FR
NOVARTIS PHARMA AG
CH
KING'S COLLEGE LONDON
UK · €293,808
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA, FUNDACION INCLIVA
ES · €257,066
AARHUS UNIVERSITET
DK · €555,713
UNIVERSITAET MUENSTER
DE · €1,064,750
REGION HOVEDSTADEN
DK · €7,500
MICHIGAN STATE UNIVERSITY
US · €29,549
INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR-IBMC
PT · €351,901
HUS-YHTYMA
FI · €187,250
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
FR · €881,329
CONSULTECH TECHNOLOGIEBERATUNG GMBH
DE · €486,266
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IL
PROMPTLY - SOFTWARE SOLUTIONS FOR HEALTH MEASURES SA
PT · €30,000
ACTUAL ANALYTICS LTD
UK · €114,413
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
FR · €295,038
EUROPEAN SOCIETY OF ANAESTHESIOLOGY AND INTENSIVE CARE AISBL
BE · €25,000
UNIVERSITE CATHOLIQUE DE LOUVAIN
BE · €552,488
CLINIQUES UNIVERSITAIRES SAINT-LUC ASBL
BE · €134,044
CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL
DE · €255,000
EUROPEAN SOCIETY OF REGIONAL ANAESTHESIA AND PAIN THERAPY
CH · €25,000
MRC SYSTEMS GMBH MEDIZINTECHNISCHE SYSTEME
DE · €144,000
NEUROSCIENCE TECHNOLOGIES SLP
ES
UNIVERSIDAD DE NAVARRA
ES · €123,500
CHILDREN'S HOSPITAL CORPORATION
US · €165,668
STICHTING INTERNATIONAL PAINFUL BLADDER FOUNDATION
NL · €7,510
ENDOMETRIOSIS.ORG LTD
UK · €7,510
GRUNENTHAL GMBH
DE
BAYER AKTIENGESELLSCHAFT
DE
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
UK · €1,592,860
EUROPEAN PAIN FEDERATION EFIC
BE · €31,250
QUEEN MARY UNIVERSITY OF LONDON
UK · €21,484
ESTEVE PHARMACEUTICALS, SA
ES
ELI LILLY AND COMPANY LTD
UK
UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
IE · €68,687
AALBORG UNIVERSITET
DK · €18,770
PELVIC PAIN SUPPORT NETWORK
UK · €7,510
THE UNIVERSITY OF EDINBURGH
UK · €288,953
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA
IT · €573,288
UNIVERSITATSKLINIKUM JENA
DE · €1,608,584
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.